Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid

Background: The search for a biomarker of Alzheimer’s disease (AD) pathology (amyloid-β (Aβ) and tau) is ongoing, with the best markers currently being measurements of Aβ and tau in cerebrospinal fluid (CSF) and via positron emission tomography (PET) scanning. These methods are relatively invasive,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Alzheimers Dis
Main Authors: Voyle, Nicola, Patel, Hamel, Folarin, Amos, Newhouse, Stephen, Johnston, Caroline, Visser, Pieter Jelle, Dobson, Richard J.B., Kiddle, Steven J.
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5181674/
https://ncbi.nlm.nih.gov/pubmed/27834776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-160707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados